health
AI brings savings to clinical trials: study
New research shows it's starting to unlock millions of dollars' worth of new efficiencies.
TL;DR
- AI is speeding up clinical trials for cancer treatments, leading to significant time and cost savings.
- AI-powered tools can reduce time spent on patient recruitment, monitoring, and data interpretation.
- A Tufts study found AI agents can accelerate late-stage cancer drug trials by approximately 10 weeks and cut costs by up to $5.6 million.
- AI could become a standard feature in clinical trials within three to five years, similar to self-driving cars for record-keeping.
- AI can help track trial population diversity and allow researchers to understand drug safety and effectiveness earlier.
- Challenges remain, including finding the right patients, obtaining consent, manufacturing, and distribution.
- Human verification of AI work may offset some of the time savings.